GlassScriptPhysician profile
Manu Kaushik
NPI 1740489202
$12,077.99
in general payments reported to CMS, 2019-2025
33 companies · $2,849 in 2025
The $2,849 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,537 · 2020: $910 · 2021: $580 · 2022: $846 · 2023: $1,300 · 2024: $3,055 · 2025: $2,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,374 · Travel and Lodging: $1,831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,374.04 |
| Travel and Lodging | $1,830.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,686.02 | 2019-2025 | Triclip, Mitraclip, Xience Skypoint |
| Edwards Lifesciences Corporation | $1,592.56 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Boston Scientific Corporation | $1,555.50 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Watchman Access System |
| Abiomed | $1,162.35 | 2019-2025 | Impella |
| Intuitive Surgical, INC. | $1,007.54 | 2024 | |
| Medtronic, INC. | $725.80 | 2021-2025 | Corevalve Evolut R, Ffrangio, Resolute Onyx |
| Shockwave Medical, INC | $547.44 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $510.32 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $276.25 | 2024-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $272.51 | 2022-2024 | Gore Cardioform Septal Occluder |
| Janssen Pharmaceuticals, INC | $246.59 | 2019-2021 | |
| Penumbra, INC. | $211.71 | 2024-2025 | Penumbra System, Indigo System |
| Pfizer INC. | $190.31 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $119.30 | 2021-2023 | Eliquis |
| Astellas Pharma US INC | $116.39 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $101.12 | 2020-2023 | Repatha |
| Biosense Webster, INC. | $100.99 | 2024 | Carto 3 |
| Cardiovascular Systems INC. | $99.77 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $99.74 | 2021-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $93.88 | 2019-2023 | |
| Cardiva Medical, INC. | $72.47 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $51.93 | 2019-2020 | |
| Amarin Pharma, INC. | $44.94 | 2020 | |
| Teleflex LLC | $38.19 | 2022-2025 | Guideliner |
| Heartflow, INC. | $21.36 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $20.60 | 2023 | Uptravi, Opsumit |
| Getinge USA Sales, LLC | $19.54 | 2019 | |
| Cvrx, INC. | $18.92 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $17.82 | 2022 | |
| Atricure, INC. | $16.71 | 2022 | |
| Esperion Therapeutics, INC. | $13.74 | 2022 | |
| Cordis US Corp. | $13.68 | 2025 | Mynx Control Venous |
| Regeneron Healthcare Solutions, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manu Kaushik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.